Turing Biosystems
London, United Kingdom
Turing Biosystems tackles the problems of high failure rates and high toxicity in immunotherapy and cell & gene therapy. Our software platform integrates clinical and biological data to analyse patient responses to therapy and design better treatments. The platform is based on a new kind of interpretable AI, built on modern hardware and using automated reasoning. Our platform is able to integrate all types of multimodal data and information available on a patient or a cohort, such as metadata, health records, multi-omics (epigenomics to metabolomics), tissue and imaging data, public data and prior knowledge to inform the analysis. Our AI is designed to focus on clinical outcomes optimization to improve the safety and efficacy of therapies for patients, clinicians, and biopharma.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.turingdb.ai/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Turing Biosystems?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now